Document is current
Any future updates will be listed below
-
Authors
Bousbaine, Djenet https://orcid.org/0000-0003-2683-9544
Bauman, Katherine D.
Chen, Y. Erin
Lalgudi, Pranav V. https://orcid.org/0000-0003-1653-2338
Nguyen, Tam T. D.
Swenson, Joyce M.
Yu, Victor K.
Tsang, Eunice
Conlan, Sean
Li, David B. https://orcid.org/0000-0002-8921-5168
Jbara, Amina
Zhao, Aishan
Naziripour, Arash
Veinbachs, Alessandra
Lee, Yu E.
Phung, Jennie L.
Dimas, Alex
Jain, Sunit https://orcid.org/0000-0002-5888-3702
Meng, Xiandong
Pham, Thi Phuong Thao
McLaughlin, Martin I. https://orcid.org/0000-0003-4410-0786
Barkal, Layla J.
Gribonika, Inta https://orcid.org/0000-0002-5694-1315
Van Rompay, Koen K. A. https://orcid.org/0000-0002-7375-1337
Kong, Heidi H. https://orcid.org/0000-0003-4424-064X
Segre, Julia A. https://orcid.org/0000-0001-6860-348X
Belkaid, Yasmine https://orcid.org/0000-0001-9962-3571
Barnes, Christopher O. https://orcid.org/0000-0003-2754-5951
Fischbach, Michael A. https://orcid.org/0000-0003-3079-8247
- License Information
-
More Information
Article History
Received: 12 January 2024
Accepted: 4 December 2024
First Online: 11 December 2024
Competing interests
: M.A.F. is a cofounder of Kelonia and Revolution Medicines, a member of the scientific advisory boards of the Chan Zuckerberg Initiative, NGM Biopharmaceuticals and TCG Laboratories/Soleil Laboratories, and an innovation partner at The Column Group. D.B., Y.E.C., K.D.B., P.V.L., M.I.M., C.O.B., Y.B. and M.A.F. are inventors on patent applications submitted by Stanford University and the Chan Zuckerberg Biohub that cover methods for using engineered bacteria to elicit antigen-specific immune cells.
